Medicine recalls
|
| |
| Canada: Recall: TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine |
| |
Health Canada announces that Teva Canada Limited is recalling the following products from retailers and pharmacy because affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine:
- TEVA-Betahistine Tablets 8mg (lot number: 100043755, 100047041, 100054115, 100057407)
- TEVA-Betahistine Tablets 16mg (lot number: 100039202, 100039975, 100040342, 100047037, 100047038, 100048555, 100050930, 100052559, 100057107, 100057408, 100058036, 100062444, 100038357, 100047367)
- TEVA-Betahistine Tablets 24mg (lot number: 100038340, 100043738, 100049891, 100052857, 100056000, 100039609, 100039610, 100039611, 100044222, 100049365, 100058037)
TEVA-Betahistine is indicated for reducing the episodes of recurrent vertigo associated with Ménière’s disease.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/teva-betahistine-tablets-affected-lots-exceed-or-may-exceed-interim-acceptable-intake
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Thursday, Dec 5, 2024
Issued at HKT 15:30
|
| |
